Understanding the Covid-19 vaccine uptake, acceptance, and hesitancy in Ethiopia and Tanzania

A scoping review

Datos Bibliográficos

ID22073246
AutoresEsayas Kebede Gudina (0000-0002-6264-9695, Jimma University), Florida Muro (0000-0002-5127-3995, Kilimanjaro Christian Medical Centre), Florida Joseph Muro, Norman J Kyala (0000-0001-6392-8947, Kilimanjaro Christian Medical Centre), Tsegaye Melaku (0000-0001-8373-5309, Jimma University), Jane Brandt Sørensen (0000-0002-1702-280X, University of Copenhagen), Dan Wolf Meyrowitsch (0000-0003-1108-8987, University of Copenhagen), Zeleke Mekonnen (0000-0003-3418-7291, Jimma University), Tania Aase Draebel (University of Copenhagen, autor de correspondencia)
Año2024
Volumen12
Páginas1422673-1422673
Fecha de publicación2024-11-11
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaFrontiers in Public Health (JOURNAL)
Identificadores de la revistaISSN: 2296-2565 • E-ISSN: 2296-2565
EditorialFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2024.1422673
PMID39588164
OpenAlexW4404250999
IdiomaEN
Citas recibidas1
Referencias citadas104

Background: The development and implementation of COVID-19 vaccines have been a breakthrough in controlling the pandemic. However, the vaccination coverage in most low-income countries remains very low due to critical vaccine shortage and profound hesitancy. In this scoping review, we aimed to assess COVID-19 vaccine uptake, acceptance, and hesitancy in Ethiopia and Tanzania. Methods: The search was made in PubMed, Scopus, Embase, and Web of Science. Only original research articles focusing on vaccine acceptance and hesitancy were included. The studies selected for a full read were analysed using a thematic analysis approach. Findings: A total of 76 articles were included in the study, with 74 of them coming from Ethiopia. The study found an increasing trend in vaccine uptake over time. However, there was also an increase in hesitancy and a decline in willingness to receive the vaccine. The willingness to receive the COVID-19 vaccine in Ethiopia ranged from 18.5 to 88%. The main reasons for "vaccine hesitancy" included fear of side effects, concerns about long-term safety, doubts about vaccine effectiveness, lack of information, vaccine fast-tracking, and religious beliefs. The study also found that younger individuals, females, and pregnant women were less willing to receive the vaccine. The adverse events reported among vaccinated individuals were mostly mild. Most of the studies operationalised vaccine acceptance-hesitancy as dichotomous variables. However, the historical, political, and socio-cultural context in which vaccine acceptance and hesitancy occur was not given any attention. While there is a good amount of data from Ethiopia describing patterns of vaccine acceptance and hesitancy among different populations over time, there is limited information from Tanzania due to the late arrival of the vaccine and limited published articles. Conclusion: We have observed a paradox involving two seemingly conflicting trends: an increase in vaccination rates/coverage and "anti-vax." Most studies have simplified vaccine acceptance-hesitancy as an "either-or" incident, without considering its dynamic nature and occurrence within a broader political, social, and cultural context. Therefore, it is crucial to explore approaches that can enhance our understanding of the vaccine acceptance-hesitancy phenomenon, in order to improve vaccine trust and uptake

2019-20 coronavirus outbreak · Disease · Environmental health · Environmental planning · Geography · Outbreak · Pathology · Tanzania · COVID-19 Impact on Reproduction · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Virology